Speaker / Title    Paul Nagao (GW PGY-2 pathology resident)
Title of Presentation    Gene Therapy for Sickle Cell Disease: Practice Recommendations from ASTCT and ISCGT    
Date    10/22/2026
Learning Objectives    At the conclusion of this educational activity, the participant should be able to:
    1) Explain how the two approved gene therapies work and how they compare with existing treatments.
    2) Walk through the guideline’s treatment pathway, from patient selection to long-term follow-up.
    3) Identify the laboratory’s role at each step, and what has changed since publication.